Clinical Trial Update: A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants [Phase 1, Phase 2]

View source ↗

Summary

A multicenter early-phase trial evaluating safety and immunogenicity of a new malaria vaccine in Kenyan adults, children, and infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria

Snippet

Sponsor: University of Oxford | Conditions: Malaria,Falciparum | Phase 1, Phase 2 | Status: COMPLETED